Immunovant
IMVT
IMVT
120 hedge funds and large institutions have $653M invested in Immunovant in 2021 Q1 according to their latest regulatory filings, with 29 funds opening new positions, 50 increasing their positions, 30 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
48% less first-time investments, than exits
New positions opened: 29 | Existing positions closed: 56
65% less capital invested
Capital invested by funds: $1.86B → $653M (-$1.21B)
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
120
Holding in Top 10
1
Calls
$15.4M
Puts
$6.89M
Top Buyers
| 1 | +$28M | |
| 2 | +$24.7M | |
| 3 | +$17.6M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
+$16M |
| 5 |
Two Sigma Investments
New York
|
+$11.8M |
Top Sellers
| 1 | -$64.7M | |
| 2 | -$64.7M | |
| 3 | -$63.6M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$41.2M |
| 5 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$27.9M |